NEW YORK (GenomeWeb) – The US Food and Drug Administration today announced a proposal to establish procedures and criteria for the de novo classification of medical devices, including in vitro diagnostics. 

FDA Commissioner Scott Gottlieb said in a statement that the agency's goal is to make the pathway "significantly more efficient and transparent by clarifying the requirements for submission and our processes for review."

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.